{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:49:37Z","timestamp":1792194577644,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 011286"],"award-info":[{"award-number":["ZIA BC 011286"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.soc.2022.10.008","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T19:27:11Z","timestamp":1678822031000},"page":"315-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype\/Phenotype"],"prefix":"10.1016","volume":"32","author":[{"given":"Bhavishya","family":"Ramamoorthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soc.2022.10.008_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple Endocrine Neoplasia Type 1: Latest Insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.soc.2022.10.008_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12020-018-1566-8","article-title":"Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database","volume":"62","author":"Marini","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.soc.2022.10.008_bib5","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.7230.1","article-title":"Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old","volume":"6","author":"Falchetti","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.soc.2022.10.008_bib6","doi-asserted-by":"crossref","first-page":"591501","DOI":"10.3389\/fendo.2020.591501","article-title":"Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype\u2013phenotype Correlations","volume":"11","author":"Mele","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.soc.2022.10.008_bib7","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.soc.2022.10.008_bib8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.soc.2022.10.008_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.soc.2022.10.008_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.soc.2022.10.008_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF03346440","article-title":"The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis","volume":"31","author":"Marini","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"20","key":"10.1016\/j.soc.2022.10.008_bib12","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.3390\/ijms21207592","article-title":"Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome","volume":"21","author":"Donati","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2022.10.008_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6061\/clinics\/2012(Sup01)10","article-title":"Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype\u2013phenotype correlation","volume":"67","author":"Lips","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.soc.2022.10.008_bib15","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/ERC-12-0338","article-title":"Neuroendocrine tumours: cracking the epigenetic code","volume":"20","author":"Karpathakis","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.soc.2022.10.008_bib16","doi-asserted-by":"crossref","first-page":"R519","DOI":"10.1530\/ERC-19-0175","article-title":"The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours","volume":"26","author":"Pipinikas","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.soc.2022.10.008_bib17","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.3390\/ijms22084041","article-title":"Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib18","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JME-18-0050","article-title":"Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types","volume":"61","author":"Iyer","year":"2018","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.soc.2022.10.008_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.soc.2022.10.008_bib20","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1210\/jc.2003-031511","article-title":"Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma","volume":"89","author":"Hao","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.soc.2022.10.008_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ecl.2018.04.008","article-title":"The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia","volume":"47","author":"Inzani","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.soc.2022.10.008_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000499606","article-title":"Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens","volume":"109","author":"Partelli","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.soc.2022.10.008_bib24","doi-asserted-by":"crossref","first-page":"681013","DOI":"10.3389\/fendo.2021.681013","article-title":"A\u00a0Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype\u2013phenotype Correlations","volume":"12","author":"Soczomski","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.soc.2022.10.008_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MPA.0000000000000825","article-title":"Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy","volume":"46","author":"Jensen","year":"2017","journal-title":"Pancreas"},{"issue":"7","key":"10.1016\/j.soc.2022.10.008_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.soc.2022.10.008_bib27","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/ERC-19-0372","article-title":"Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature","volume":"27","author":"Sadowski","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.soc.2022.10.008_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/msy.2000.109727","article-title":"Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?","volume":"128","author":"Bartsch","year":"2000","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-018-0938-8","article-title":"Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients","volume":"13","author":"Marini","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.soc.2022.10.008_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","article-title":"True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome","volume":"65","author":"K\u00f6vesdi","year":"2019","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.soc.2022.10.008_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2017.04.044","article-title":"Genotype\u2013phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution","volume":"163","author":"Christakis","year":"2018","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.soc.2022.10.008_bib32","doi-asserted-by":"crossref","first-page":"E2387","DOI":"10.1210\/jc.2013-4432","article-title":"Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain","volume":"99","author":"Bartsch","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.soc.2022.10.008_bib33","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.soc.2022.10.008_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.21037\/jgo.2020.03.11","article-title":"Genetic and epigenetic alterations in pancreatic neuroendocrine tumors","volume":"11","author":"Tirosh","year":"2020","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.soc.2022.10.008_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/EJE-18-0195","article-title":"DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment","volume":"179","author":"Conemans","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.soc.2022.10.008_bib36","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1210\/clinem\/dgaa477","article-title":"Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition","volume":"105","author":"Tirosh","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.soc.2022.10.008_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/cncr.31930","article-title":"Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors","volume":"125","author":"Tirosh","year":"2019","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2022.10.008_bib38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/15384047.2016.1250986","article-title":"Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets","volume":"17","author":"Lin","year":"2016","journal-title":"Cancer Biol Ther"},{"issue":"33","key":"10.1016\/j.soc.2022.10.008_bib39","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1110104108","article-title":"Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.soc.2022.10.008_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1541-7786.MCR-14-0457","article-title":"Dynamic epigenetic regulation by menin during pancreatic islet tumor formation","volume":"13","author":"Lin","year":"2015","journal-title":"Mol Cancer Res"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:05:50Z","timestamp":1760961950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320722000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1055320722000886"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2022.10.008","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype\/Phenotype","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2022.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}